Physician profile
Jing Chen
NPI 1699208942
$569.96
in general payments reported to CMS, 2019-2025
6 companies · $115 in 2025
The $115 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $139 · 2023: $43.10 · 2024: $273 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373 · Travel and Lodging: $58.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.78 |
| Travel and Lodging | $58.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $188.83 | 2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Glaxosmithkline, LLC. | $158.30 | 2022-2024 | Arexvy, Shingrix, Bexsero |
| Argon Medical Devices, INC. | $115.39 | 2025 | Clot Management |
| Hologic Sales and Service, LLC | $44.71 | 2024 | Acessa Provu System |
| Cranial Technologies, INC | $39.34 | 2023-2024 | Doc Band |
| Novo Nordisk INC | $23.39 | 2023 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jing Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.